Richard C Frank

Title: Richard C Frank: Innovator in Cancer Treatment

Introduction

Richard C Frank is a notable inventor based in Fairfield, CT (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent developments. His work focuses on the role of mannan-binding protein-associated serine protease-2 (MASP-2) in cancer, leading to improved treatment methodologies.

Latest Patents

Richard C Frank holds a patent for "Extracellular vesicle derived MASP-2 directed cancer treatment methods." This patent outlines cancer treatment methods that leverage the unexpected discovery of MASP-2 as a biomarker for cancer. The methods involve measuring changes in MASP-2 levels, which can indicate cancer progression, responsiveness to chemotherapy, and remission, particularly in pancreatic cancers. The patent emphasizes the use of extracellular vesicles (EVs) from patient blood samples to provide effective and targeted cancer treatment regimens.

Career Highlights

Richard C Frank is associated with Nuvance Health, where he continues to advance his research in cancer treatment. His innovative approach has the potential to transform how cancer is diagnosed and treated, particularly through the use of MASP-2 as a biomarker.

Collaborations

Richard has collaborated with notable colleagues, including Shatovisha Dey and Deep Siddhartha Pandya. Their combined expertise contributes to the ongoing research and development of effective cancer treatment methods.

Conclusion

Richard C Frank's work in cancer treatment exemplifies the impact of innovative research on medical science. His patent on MASP-2 directed treatment methods represents a significant advancement in the fight against cancer.